149 related articles for article (PubMed ID: 28910072)
1. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.
Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K
ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072
[TBL] [Abstract][Full Text] [Related]
2. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
4. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
[TBL] [Abstract][Full Text] [Related]
5. Genetically encoded photocrosslinkers locate the high-affinity binding site of antidepressant drugs in the human serotonin transporter.
Rannversson H; Andersen J; Sørensen L; Bang-Andersen B; Park M; Huber T; Sakmar TP; Strømgaard K
Nat Commun; 2016 Apr; 7():11261. PubMed ID: 27089947
[TBL] [Abstract][Full Text] [Related]
6. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
Chen F; Larsen MB; Sánchez C; Wiborg O
Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
[TBL] [Abstract][Full Text] [Related]
7. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
Plenge P; Gether U; Rasmussen SG
Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
[TBL] [Abstract][Full Text] [Related]
8. Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.
Kumar V; Yarravarapu N; Lapinsky DJ; Perley D; Felts B; Tomlinson MJ; Vaughan RA; Henry LK; Lever JR; Newman AH
J Med Chem; 2015 Jul; 58(14):5609-19. PubMed ID: 26153715
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for recognition of diverse antidepressants by the human serotonin transporter.
Coleman JA; Gouaux E
Nat Struct Mol Biol; 2018 Feb; 25(2):170-175. PubMed ID: 29379174
[TBL] [Abstract][Full Text] [Related]
10. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
11. Chemical and structural investigation of the paroxetine-human serotonin transporter complex.
Coleman JA; Navratna V; Antermite D; Yang D; Bull JA; Gouaux E
Elife; 2020 Jul; 9():. PubMed ID: 32618269
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.
Davis BA; Nagarajan A; Forrest LR; Singh SK
Sci Rep; 2016 Apr; 6():23789. PubMed ID: 27032980
[TBL] [Abstract][Full Text] [Related]
13. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
[TBL] [Abstract][Full Text] [Related]
14. A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter.
Slack RD; Abramyan AM; Tang H; Meena S; Davis BA; Bonifazi A; Giancola JB; Deschamps JR; Naing S; Yano H; Singh SK; Newman AH; Shi L
ACS Chem Neurosci; 2019 Sep; 10(9):3946-3952. PubMed ID: 31424193
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of Na+/Cl(-)-dependent neurotransmitter transporters in a membrane-aqueous system.
Jørgensen AM; Tagmose L; Jørgensen AM; Bøgesø KP; Peters GH
ChemMedChem; 2007 Jun; 2(6):827-40. PubMed ID: 17436258
[TBL] [Abstract][Full Text] [Related]
16. X-ray structures and mechanism of the human serotonin transporter.
Coleman JA; Green EM; Gouaux E
Nature; 2016 Apr; 532(7599):334-9. PubMed ID: 27049939
[TBL] [Abstract][Full Text] [Related]
17. Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter.
Combs S; Kaufmann K; Field JR; Blakely RD; Meiler J
ACS Chem Neurosci; 2011 Feb; 2(2):75-81. PubMed ID: 22778858
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.
Sánchez C
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):91-5. PubMed ID: 16918708
[TBL] [Abstract][Full Text] [Related]
19. Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
Andersen J; Taboureau O; Hansen KB; Olsen L; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2009 Apr; 284(15):10276-84. PubMed ID: 19213730
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram.
Xue W; Fu T; Deng S; Yang F; Yang J; Zhu F
ACS Chem Neurosci; 2022 Feb; 13(3):340-351. PubMed ID: 35041375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
